A toxicological assessment of spermidine trihydrochloride produced using an engineered strain of Saccharomyces cerevisiae.

Spermidine is a polyamine consumed in the diet, endogenously biosynthesized in most cells, and produced by the intestinal microbiome. A variety of foods contribute to intake of spermidine along with other polyamines. Spermidine trihydrochloride (spermidine-3HCl) of high purity can be produced using an engineered strain of Saccharomyces cerevisiae. Spermidine has a demonstrated history of safe use in the diet; however, limited information is available in the public literature to assess the potential toxicity of spermidine-3HCl. To support a safety assessment for this spermidine-3HCl as a dietary source of spermidine, authoritative guideline and good laboratory practice (GLP) compliant in vitro genotoxicity assays (bacterial reverse mutation and mammalian micronucleus assays) and a 90-day oral (dietary) toxicity study in rats were conducted with spermidine-3HCl. Spermidine-3HCl was non-genotoxic in the in vitro assays, and no adverse effects were reported in the 90-day oral toxicity study up to the highest dose tested, 12500 ppm, equivalent to 728 mg/kg bw/day for males and 829 mg/kg bw/day for females. The subchronic no observed adverse effect level (NOAEL) is 728 mg/kg bw/day.
Competing Interests: Declaration of competing interest Patrick Keohane and Rui Pereria are employees of Chrysea Labs Lda, which sponsored the studies presented in this paper. Paola P. Chrysostomou, Elaine L. Freeman, and Mary M. Murphy are employees of Exponent, Inc.; Chrysea Labs Lda is a client of Exponent, Inc. David J. Esdaile is an employee of Charles River Laboratories Hungary, Kft. where the study was conducted; Chrysea Labs Lda is a client of Charles River Laboratories. Sprevive® is a registered trademark of Chrysea Labs Lda.
(Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.)